Pharvaris N.V. Financial Statements
NASDAQ: PHVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
31.80+0.675 (+2.17%)
Market open · Delayed 15 min · as of Oct 9, 2:37 PM ET
Pharvaris N.V. revenue and earnings
Pharvaris N.V. reported a net loss of $26.0 million, compared with a loss of $8.0 million a year earlier.
Summary generated from market data by MetaCap's automated system. Methodology
Pharvaris N.V. income statement (annual)
| Fiscal year (USD) | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|
| Net Income | -25.99M | -8.03M | -4.31M |
| Net Income growth (YoY) | — | — | — |
| Shares Outstanding (Diluted) | 4.85M | 4.85M | 4.85M |
This table shows 3 annual periods of Pharvaris N.V.'s income statement, from FY 2020 back to FY 2018, across 2 line items including net income, shares outstanding (diluted). Values in USD; B = billions, M = millions. Fiscal periods follow PHVS's reporting calendar. What is a income statement?